University of Texas Southwestern Medical Center, Hamon Ctr for Therapeutic Oncology Research, Assistant Professor

2007.4 - 2007.9

American Association for Cancer Research

日本アレルギー学会

日本学術振興会 若手研究（A）細目名：呼吸器内科学　   第1段審査（書面審査）委員　平成29年度  

2016.11 - 2017.12   

日本学術振興会 基盤研究（B）細目名：呼吸器内科学　   第1段審査（書面審査）委員　平成29年度  

2016.11 - 2017.12   

日本呼吸器学会   代議員  

2020.1 - 2021.12   

日本癌学会   評議員  

2020.1   

日本学術振興会   医歯薬領域・特別研究員等審査会専門委員  

2021.6 - 2023.6   

Oxytocin receptor is a promising therapeutic target of malignant mesothelioma Invited Reviewed

Yuta Kodama, Ichidai Tanaka, Tatsuhiro Sato, Kazumi Hori, Soei Gen, Masahiro Morise, Daisuke Matsubara, Mitsuo Sato, Yoshitaka Sekido, Naozumi Hashimoto

Cancer Science     2021.9

(Review article) Immortalized normal human lung epithelial cell models for studying lung cancer biology Reviewed

Mitsuo Sato, Jerry W. Shay, John D. Minna

Respiratory Investigation   Vol. 0000 ( 0000 ) page： 0000   2020.7

UHRF1, a regulator of methylation, as a diagnostic and prognostic marker for lung cancer Reviewed

Daiki Goto, Kazuki Komeda, Natsuki Uwatoko, Moeka Nakashima, Mayu Koike, Kaho Kawai, Yuta Kodama, Ayako Miyazawa, Ichidai Tanaka, Tetsunari Hase, Masahiro Morise, Yoshinori Hasegawa, Tsutomu Kawabe, Mitsuo Sato (corresponding author)

Cancer Investigation   Vol. 38   page： 240-249   2020.4

Risk factors for pulmonary infection after diagnostic bronchoscopy in patients with lung cancer. Reviewed

Shimizu T, Okachi S, Imai N, Hase T, Morise M, Hashimoto N, Sato M, Hasegawa Y

Nagoya J Med Sci   Vol. 82   page： 69-77   2020.2

(Review article) Phenotypic screening with large-scale genomic libraries to discover drug targets for cancer Reviewed

Mitsuo Sato

Oncology Letters     page： In Press   2020.1

(Editorial) Chemotherapy induced changes to fibrin clots properties in lung cancer:Is it favorable?

Mitsuo Sato

Journal of Thoracic Disease     page： In press   2019.5

Exploration of germline variants responsible for adverse events of crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer by target-gene panel sequencing. Reviewed

Mizugaki H, Hamada A, Shibata T, Hosoda F, Nakamura H, Okuma Y, Shukuya T, Umemura S, Horiike A, Fukui T, Kogure Y, Daga H, Urata Y, Yamada K, Saeki S, Fujisaka Y, Nakamura Y, Sato M, Yoshida T, Hotta T, Oizumi S, Fujiwara Y, Ohe Y, Fujiwara Y.

Lung Cancer   Vol. 128   page： 20-25   2019

A 65-nm CMOS Fully Integrated Analysis Platform Using an On-Chip Vector Network Analyzer and a Transmission-Line-Based Detection Window for Analyzing Circulating Tumor Cell and Exosome. Reviewed

Niitsu K, Nakanishi T, Murakami S, Matsunaga M, Kobayashi A, Karim NM, Ito J, Ozawa N, Hase T, Tanaka H, Sato M, Kondo H, Ishikawa K, Odaka H, Hasegawa Y, Hori M, Nakazato K.

IEEE Trans Biomed Circuits Syst.   Vol. 13   page： 470-479.   2019

Potential for afatinib as an optimal treatment for advanced non-small cell lung carcinoma in patients with uncommon EGFR mutations. Reviewed

Tanaka I, Morise M, Kodama Y, Matsui A, Ozawa N, Ozone S, Goto D, Miyazawa A, Hase T, Hashimoto N, Sato M, Hasegawa Y

Lung Cancer.   Vol. 127   page： 169-171   2019

(Editorial) Specific Copy Number Changes as Potential Predictive Markers for Adjuvant Chemotherapy in Non-Small Cell Lung Cancer Invited Reviewed

Mitsuo Sato

Translational Lung Cancer Research     page： In press   2018.12

An EGFR-mutated Lung Adenocarcinoma Undergoing Squamous Cell Carcinoma Transformation Exhibited a Durable Response to Afatinib. Reviewed

Sato M, Matsui A, Shimoyama Y, Omote N, Morise M, Hase T, Tanaka I, Suzuki K, Hasegawa Y.

Intern Med.     2018.8

Pseudomembranous Invasive Tracheobronchial Aspergillosis with Fulminant Hepatitis and Hemophagocytic Syndrome. Reviewed

Majima S, Okachi S, Asano M, Wakahara K, Hashimoto N, Sato M, Ishigami M, Hasegawa Y.

Intern Med.   Vol. 57   page： 2371-2375   2018.8

eIF2β, a Subunit of Translation-Initiation Factor EIF2, Is a Potential Therapeutic Target for Non-Small Cell Lung Cancer.

Tanaka I, Sato M (corresponding author), Kato T, Goto D, Kakumu T, Miyazawa A, Yogo N, Hase T, Morise M, Sekido Y, Girard L, Minna JD, Byers LA, Heymach JV, Coombes KR, Kondo M, Hasegawa Y.

Cancer Sci.     page： 10.1111/cas.13602.   2018.4

Safety and efficacy of diagnostic flexible bronchoscopy in very old patients with lung cancer Reviewed

Shotaro Okachi, Kazuyoshi Imaizumi, Naoyuki Imai, Takahiro Shimizu, Tetsunari Hase, Masahiro Morise, Naozumi Hashimoto, Mitsuo Sato, Yoshinori Hasegawa

European Geriatric Medicine   Vol. 9   page： 255-262   2018.2

Lung Metastases from Bile Duct Adenocarcinoma Mimicking Chronic Airway Infection and Causing Diagnostic Difficulty.

Sato M, Okachi S, Fukihara J, Shimoyama Y, Wakahara K, Sakakibara T, Hase T, Onishi Y, Ogura Y, Maeda O, Hasegawa Y.

Intern Med.     page： 10.2169/internalmedicine.9718-17.   2017.12

Regulation of PD-L1 expression by matrix stiffness in lung cancer cells. Reviewed

Miyazawa A, Ito S, Asano S, Tanaka I, Sato M, Kondo M, Hasegawa Y

Biochemical and biophysical research communications     2017.12

Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer. Reviewed

Kakumu T, Sato M (corresponding author), Goto D, Kato T, Yogo N, Hase T, Morise M, Fukui T, Yokoi K, Sekido Y, Girard L, Minna JD, Byers LA, Heymach JV6, Coombes KR, Kondo M, Hasegawa Y

Cancer Sci.   Vol. 108   page： 732-743   2017.4

ZEB1 drives epithelial-to-mesenchymal transition in lung cancer. Reviewed

Larsen JE, Nathan V, Osborne JK, Farrow RK, Deb D, Sullivan JP, Dospoy PD, Augustyn A, Hight SK, Sato M, Girard L, Behrens C, Wistuba II, Gazdar AF, Hayward NK, Minna JD.

J Clin Invest.     2016.8

Nuclear Receptor Expression and Function in Human Lung Cancer Pathogenesis. Reviewed

  Vol. 10   page： e0134842   2015.8

Growth inhibitory effects of miR-221 and miR-222 in non-small cell lung cancer cells. Reviewed

Yamashita R, Sato M, Kakumu T, Hase T, Yogo N, Maruyama E, Sekido Y, Kondo M, Hasegawa Y.

Cancer Med.   Vol. 4   page： 551-564   2015.4

Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations. Reviewed

Sato M, Larsen JE, Lee W, Sun H, Shames DS, Dalvi MP, Ramirez RD, Tang H, Dimaio JM, Gao B, Xie Y, Wistuba II, Gazdar AF, Shay JW, Minna JD.

    page： Epub ahead of print   2013

Primary prophylaxis indication for docetaxel induced febrile neutropenia in elderly patients with non-small cell lung cancer

Akira Matsui;Masahiro Morise;Ichidai Tanaka;Sachiko Ozone;Reiko Matsuzawa;Junji Koyama;Tetsunari Hase;Naozumi Hashimoto;Mitsuo Sato;Yoshinori Hasegawa

Cancer Investigation   Vol. In press ( In press ) page： 1-19   2020.8

Exploration of germline variants responsible for adverse events of crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer by target-gene panel sequencing. Reviewed

Mizugaki H, Hamada A, Shibata T, Hosoda F, Nakamura H, Okuma Y, Shukuya T, Umemura S, Horiike A, Fukui T, Kogure Y, Daga H, Urata Y, Yamada K, Saeki S, Fujisaka Y, Nakamura Y, Sato M, Yoshida T, Hotta T, Oizumi S, Fujiwara Y, Ohe Y, Fujiwara Y.

Lung Cancer.   Vol. 128   page： 20-25   2018.12

NeuroD1 regulates survival and migration of neuroendocrine lung carcinomas via signaling molecules TrkB and NCAM. Reviewed

Osborne JK, Larsen JE, Shields MD, Gonzales JX, Shames DS, Sato M, Kulkarni A, Wistuba II, Girard L, Minna JD, Cobb MH.

Proc Natl Acad Sci U S A.   Vol. 110 ( 16 ) page： 6524-9   2013

(Review article) Emerging evidence of Epithelial-to-Mesenchymal Transition in lung carcinogenesis. Invited Reviewed

Sato M, Shames DS, Hasegawa Y.

Respirology.     2012

Nongenomic effects of fluticasone propionate and budesonide on human airway anion secretion. Reviewed

Mizutani T, Morise M, Ito Y, Hibino Y, Matsuno T, Ito S, Hashimoto N, Sato M, Kondo M, Imaizumi K, Hasegawa Y.

Am J Respir Cell Mol Biol   Vol. 47   page： 645   2012

Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer. Reviewed

Sunaga N, Kaira K, Imai H, Shimizu K, Nakano T, Shames DS, Girard L, Soh J, Sato M, Iwasaki Y, Ishizuka T, Gazdar AF, Minna JD, Mori M.

Oncogene.     page： 10.1038/onc   2012

NeuroD1 regulation of migration accompanies the differential sensitivity of neuroendocrine carcinomas to TrkB inhibition. Reviewed

Osborne JK, Larsen JE, Gonzales JX, Shames DS, Sato M, Wistuba II, Girard L, Minna JD, Cobb MH.

Oncogenesis     2013

The circadian clock gene BMAL1 is a novel therapeutic target for malignant pleural mesothelioma. Reviewed

Elshazley M, Sato M, Hase T, Yamashita R, Yoshida K, Toyokuni S, Ishiguro F, Osada H, Sekido Y, Yokoi K, Usami N, Shames DS, Kondo M, Gazdar AF, Minna JD, Hasegawa Y.

Int J Cancer.     2012

Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer. Reviewed

Sunaga N, Imai H, Shimizu K, Shames DS, Kakegawa S, Girard L, Sato M, Kaira K, Ishizuka T, Gazdar AF, Minna JD, Mori M.

Int J Cancer.   Vol. 130   page： 1733   2012

STIM1 regulates platelet-derived growth factor-induced migration and Ca2+ influx in human airway smooth muscle cells. Reviewed

Suganuma N, Ito S, Aso H, Kondo M, Sato M, Sokabe M, Hasegawa Y.

PLoS One   Vol. 7   page： e45056   2012

Echoic features of lymph nodes with sarcoidosis determined by endobronchial ultrasound. Reviewed

Imai N, Imaizumi K, Ando M, Shimokata T, Ogawa T, Ito S, Hashimoto N, Sato M, Kondo M, Hasegawa Y.

Intern Med.   Vol. 52 ( 13 ) page： 1473-8   2013

Capsaicinoids regulate airway anion transporters through Rho kinase- and cyclic AMP-dependent mechanisms.

Hibino Y, Morise M, Ito Y, Mizutani T, Matsuno T, Ito S, Hashimoto N, Sato M, Kondo M, Imaizumi K, Hasegawa Y.

Am J Respir Cell Mol Biol   Vol. 45   page： 684   2011

Pleural plaque profiles on the chest radiographs and CT scans of asbestos-exposed Japanese construction workers. Reviewed

Elshazley M, Shibata E, Hisanaga N, Ichihara G, Ewis AA, Kamijima M, Ichihara S, Sakai K, Sato M, Kondo M, Hasegawa Y.

Ind Health   Vol. 49   page： 626   2011

Pivotal role of epithelial cell adhesion molecule in the survival of lung cancer cells. Reviewed

Hase T, Sato M, Yoshida K, Girard L, Takeyama Y, Horio M, Elshazley M, Oguri T, Sekido Y, Shames DS, Gazdar AF, Minna JD, Kondo M, Hasegawa Y.

Cancer Sci.   Vol. 102   page： 1493   2011

Aqueous fraction of Sauropus androgynus might be responsible for bronchiolitis obliterans. Reviewed

Hashimoto I, Imaizumi K, Hashimoto N, Furukawa H, Noda Y, Kawabe T, Honda T, Ogawa T, Matsuo M, Imai N, Ito S, Sato M, Kondo M, Shimokata K, Hasegawa Y.

Respirology   Vol. 18   page： 340   2013

Transient but Not Stable ZEB1 Knockdown Dramatically Inhibits Growth of Malignant Pleural Mesothelioma Cells. Reviewed

Horio M, Sato M, Takeyama Y, Elshazley M, Yamashita R, Hase T, Yoshida K, Usami N, Yokoi K, Sekido Y, Kondo M, Toyokuni S, Gazdar AF, Minna JD, Hasegawa Y.

Ann Surg Oncol.     2011

Knockdown of oncogenic KRAS in non-small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy. Reviewed

Sunaga N, Shames DS, Girard L, Peyton M, Larsen JE, Imai H, Soh J, Sato M, Yanagitani N, Kaira K, Xie Y, Gazdar AF, Mori M, Minna JD.

Mol Cancer Ther.   Vol. 10   page： 336   2011

TIMELESS is overexpressed in lung cancer and its expression correlates with poor patient survival. Reviewed

Yoshida K, Sato M, Hase T, Elshazley M, Yamashita R, Usami N, Taniguchi T, Yokoi K, Nakamura S, Kondo M, Girard L, Minna JD, Hasegawa Y.

Cancer Sci.     2013

Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells. Reviewed

Takeyama Y, Sato M, Horio M, Hase T, Yoshida K, Yokoyama T, Nakashima H, Hashimoto N, Sekido Y, Gazdar AF, Minna JD, Kondo M, Hasegawa Y.

Cancer letters   Vol. 296   page： 216-224   2010.10

Associations between oxaliplatin-induced peripheral neuropathy and polymorphisms of the ERCC1 and GSTP1 genes. Reviewed

Int J Clin Pharmacol Ther.   Vol. 48   page： 729-34   2010

Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer. Reviewed

Kwei, K.A., Kim, Y.H., Girard, L., Kao, J., Pacyna-Gengelbach, M., Salari, K., Lee, J., Choi, Y.L., Sato, M., Wang, P., Hernandez-Boussard, T., Gazdar, A.F., Petersen, I., Minna, J.D. & Pollack, J.R.

Oncogene   Vol. 27   page： 3635-40   2008

EGFR-TKI resistance due to BIM polymorphism can be circumvented by in combination with HDAC inhibition. Reviewed

Nakagawa T, Takeuchi S, Yamada T, Ebi H, Sano T, Nanjo S, Ishikawa D, Sato M, Hasegawa Y, Sekido Y, Yano S.

Cancer Res     page： Epub ahead of print]   2013

PIK3CA mutations and copy number gains in human lung cancers. 68, 6913-21, 2008. Reviewed

  Vol. 68   page： 6913-21   2008

Endobronchial ultrasound transbronchial needle aspiration in older people. Reviewed

Okachi S, Imai N, Imaizumi K, Hase T, Shindo Y, Sakamoto K, Aso H, Wakahara K, Hashimoto I, Ito S, Hashimoto N, Sato M, Kondo M, Hasegawa Y.

Geriatr Gerontol Int     page： 10.1111/ggi   2013

Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mouse model of lung cancer. Reviewed

Iwanaga, K., Yang, Y., Raso, M.G., Ma, L., Hanna, A.E., Thilaganathan, N., Moghaddam, S., Evans, C.M., Li, H., Cai, W.W., Sato, M., Minna, J.D., Wu, H., Creighton, C.J., Demayo, F.J., Wistuba, II & Kurie, J.M.

Cancer Res   Vol. 68   page： 1119-27   2008

Involvement of the transcription factor twist in phenotype alteration through epithelial-mesenchymal transition in lung cancer cells. Reviewed

Nakashima H, Hashimoto N, Aoyama D, Kohnoh T, Sakamoto K, Kusunose M, Imaizumi K, Takeyama Y, Sato M, Kawabe T, Hasegawa Y.

Mol Carcinog   Vol. 51   page： 400   2012

Comparisons of tyrosine phosphorylated proteins in cells expressing lung cancer-specific alleles of EGFR and KRAS. Reviewed

Guha, U., Chaerkady, R., Marimuthu, A., Patterson, A.S., Kashyap, M.K., Harsha, H.C., Sato, M., Bader, J.S., Lash, A.E., Minna, J.D., Pandey, A. & Varmus, H.E.

Proc Natl Acad Sci U S A   Vol. 105   page： 14112-7   2008

Characterizing the cancer genome in lung adenocarcinoma. Reviewed

Weir, B.A., Woo, M.S., Getz, G., Perner, S., Ding, L., Beroukhim, R., Lin, W.M., Province, M.A., Kraja, A., Johnson, L.A., Shah, K., Sato, M., Thomas, R.K., Barletta, J.A., Borecki, I.B., Broderick, S., Chang, A.C., Chiang, D.Y., Chirieac, L.R., Cho, J., Fujii, Y., Gazdar, A.F., Giordano, T., Greulich, H., Hanna, M., Johnson, B.E., Kris, M.G., Lash, A., Lin, L., Lindeman, N., Mardis, E.R., McPherson, J.D., Minna, J.D., Morgan, M.B., Nadel, M., Orringer, M.B., Osborne, J.R., Ozenberger, B., Ramos, A.H., Robinson, J., Roth, J.A., Rusch, V., Sasaki, H., Shepherd, F., Sougnez, C., Spitz, M.R., Tsao, M.S., Twomey, D., Verhaak, R.G., Weinstock, G.M., Wheeler, D.A., Winckler, W., Yoshizawa, A., Yu, S., Zakowski, M.F., Zhang, Q., Beer, D.G., Wistuba, II, Watson, M.A., Garraway, L.A., Ladanyi, M., Travis, W.D., Pao, W., Rubin, M.A., Gabriel, S.B., Gibbs, R.A., Varmus, H.E., Wilson, R.K., Lander, E.S. & Meyerson, M.

Nature   Vol. 450   page： 893-8   2007

(Review article) A translational view of the molecular pathogenesis of lung cancer. Invited Reviewed

Sato, M., Shames, D.S., Gazdar, A.F. & Minna, J.D.

J Thorac Oncol   Vol. 2   page： 327-43   2007

Epidermal growth factor receptors with tyrosine kinase domain mutations exhibit reduced Cbl association, poor ubiquitylation, and down-regulation but are efficiently internalized. Reviewed

Padron, D., Sato, M., Shay, J.W., Gazdar, A.F., Minna, J.D. & Roth, M.G.

Cancer Res   Vol. 67   page： 7695-702   2007

EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity. Reviewed

Vikis, H., Sato, M. (equal contribution), James, M., Wang, D., Wang, Y., Wang, M., Jia, D., Liu, Y., Bailey-Wilson, J.E., Amos, C.I., Pinney, S.M., Petersen, G.M., de Andrade, M., Yang, P., Wiest, J.S., Fain, P.R., Schwartz, A.G., Gazdar, A., Gaba, C., Rothschild, H., Mandal, D., Kupert, E., Seminara, D., Viswanathan, A., Govindan, R., Minna, J., Anderson, M.W. & You, M.

Cancer Res   Vol. 67   page： 4665-70   2007

EGFR signaling is required for TGF-beta 1 mediated COX-2 induction in human bronchial epithelial cells. Reviewed

Liu, M., Yang, S.C., Sharma, S., Luo, J., Cui, X., Peebles, K.A., Huang, M., Sato, M., Ramirez, R.D., Shay, J.W., Minna, J.D. & Dubinett, S.M.

Am J Respir Cell Mol Biol   Vol. 37   page： 578-88   2007

Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells. Reviewed

Lea, J.S., Sunaga, N., Sato, M., Kalahasti, G., Miller, D.S., Minna, J.D. & Muller, C.Y.

Reprod Sci   Vol. 14,   page： 20-8   2007

Somatic mutations in the tyrosine kinase domain of epidermal growth factor receptor (EGFR) abrogate EGFR-mediated radioprotection in non-small cell lung carcinoma. Reviewed

Das, A.K., Chen, B.P., Story, M.D., Sato, M., Minna, J.D., Chen, D.J. & Nirodi, C.S.

Cancer Res   Vol. 67   page： 5267-74   2007

High Expression of Ligands for Chemokine Receptor CXCR2 in Alveolar Epithelial Neoplasia Induced by Oncogenic Kras. Reviewed

Wislez, M., Fujimoto, N., Izzo, J.G., Hanna, A.E., Cody, D.D., Langley, R.R., Tang, H., Burdick, M.D., Sato, M., Minna, J.D., Mao, L., Wistuba, I., Strieter, R.M. & Kurie, J.M.

Cancer Res   Vol. 66   page： 4198-4207   2006

A genome-wide screen for pormoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. Reviewed

Shames, D.S., Girard, L., Gao, B., Sato, M., Lewis, C.M., Shivapurkar, N., Jiang, A., Perou, C.M., Kim, Y.H., Pollack, J.R., Fong, K.M., Lam, C., Wong, M., Shyr, Y., Nanda, R., Olopade, O.I., Gerald, W., Euhus, D.M., Shay, J.W., Gazdar, A.F. & Minna, J.D.

PLOS medicine   Vol. 3   page： e486   2006

Non-Small Cell Lung Cancers with Kinase Domain Mutations in the Epidermal Growth Factor Receptor Are Sensitive to Ionizing Radiation. Reviewed

Das, A.K., Sato, M., Story, M.D., Peyton, M., Graves, R., Redpath, S., Girard, L., Gazdar, A.F., Shay, J.W., Minna, J.D. & Nirodi, C.S.

Cancer Res   Vol. 66   page： 9601-9608   2006

Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Reviewed

Sato, M., Vaughan, M.B., Girard, L., Peyton, M., Lee, W., Shames, D.S., Ramirez, R.D., Sunaga, N., Gazdar, A.F., Shay, J.W. & Minna, J.D.

Cancer Res   Vol. 66   page： 2116-28   2006

The 3p21 candidate tumor suppressor gene BAF180 is normally expressed in human lung cancer. Reviewed

Sekine, I., Sato, M., Sunaga, N., Toyooka, S., Peyton, M., Parsons, R., Wang, W., Gazdar, A.F. & Minna, J.D.

Oncogene   Vol. 24   page： 2735-8   2005

High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptor. Reviewed

Fujimoto, N., Wislez, M., Zhang, J., Iwanaga, K., Dackor, J., Hanna, A.E., Kalyankrishna, S., Cody, D.D., Price, R.E., Sato, M., Shay, J.W., Minna, J.D., Peyton, M., Tang, X., Massarelli, E., Herbst, R., Threadgill, D.W., Wistuba, II & Kurie, J.M.

Cancer Res   Vol. 65   page： 11478-85   2005

Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer. Reviewed

Sunaga, N., Miyajima, K., Suzuki, M., Sato, M., White, M.A., Ramirez, R.D., Shay, J.W., Gazdar, A.F. & Minna, J.D.

Cancer Res   Vol. 64   page： 4277-85   2004

Pulmonary cryptococcosis with a solitary focal ground-glass opacity on high-resolution computed tomography. Reviewed

Sato, M., Okamoto, M., Takagi, Y., Ikeda, T., Niimi, T., Fukatsu, E., Maruyama, K., Nara, Y., Shimokata, K. & Hasegawa, Y.

Intern Med   Vol. 43   page： 117-9   2004

Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Reviewed

Ramirez, R.D., Sheridan, S., Girard, L., Sato, M., Kim, Y., Pollack, J., Peyton, M., Zou, Y., Kurie, J.M., Dimaio, J.M., Milchgrub, S., Smith, A.L., Souza, R.F., Gilbey, L., Zhang, X., Gandia, K., Vaughan, M.B., Wright, W.E., Gazdar, A.F., Shay, J.W. & Minna, J.D.

Cancer Res   Vol. 64   page： 9027-34   2004

Increased expression and no mutation of the Flap endonuclease (FEN1) gene in human lung cancer. Reviewed

Sato, M., Girard, L., Sekine, I., Sunaga, N., Ramirez, R.D., Kamibayashi, C. & Minna, J.D.

Oncogene   Vol. 22   page： 7243-6   2003

Establishment of a large cell lung cancer cell line (Y-ML-1B) producing granulocyte colony-stimulating factor. Reviewed

Sekido, Y., Sato, M., Usami, N., Shigemitsu, K., Mori, S., Maeda, O., Yokoi, T., Hasegawa, Y., Yoshioka, H. & Shimokata, K.

Cancer Genet Cytogenet   Vol. 137   page： 33-42   2002

The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines. Reviewed

Sato, M., Horio, Y., Sekido, Y., Minna, J.D., Shimokata, K. & Hasegawa, Y.

Oncogene   Vol. 21   page： 4822-9   2002

Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion. Reviewed

Shigemitsu, K., Sekido, Y., Usami, N., Mori, S., Sato, M., Horio, Y., Hasegawa, Y., Bader, S.A., Gazdar, A.F., Minna, J.D., Hida, T., Yoshioka, H., Imaizumi, M., Ueda, Y., Takahashi, M. & Shimokata, K.

Oncogene   Vol. 20   page： 4249-57   2001

Autologous blood-patch pleurodesis for secondary spontaneous pneumothorax with persistent air leak. Reviewed

Ando, M., Yamamoto, M., Kitagawa, C., Kumazawa, A., Sato, M., Shima, K., Watanabe, A., Shimokata, K. & Hasegawa, Y.

Respir Med   Vol. 93   page： 432-4   1999

Phase I/II and pharmacologic study of irinotecan and carboplatin for patients with lung cancer. Reviewed

Sato, M., Ando, M., Minami, H., Ando, Y., Yamamoto, M., Sakai, S., Watanabe, A., Ikeda, T., Sekido, Y., Saka, H., Shimokata, K. & Hasegawa, Y.

Cancer Chemother Pharmacol   Vol. 48   page： 481-7   2001

Infrequent mutation of the hBUB1 and hBUBR1 genes in human lung cancer. Reviewed

Sato, M., Sekido, Y., Horio, Y., Takahashi, M., Saito, H., Minna, J.D., Shimokata, K. & Hasegawa, Y.

Jpn J Cancer Res   Vol. 91   page： 504-9   2000

上皮間養系細胞転換（EMT)の安定化因子を標的とする肺がん治療開発

2018.8 - 2019.3

第43回（平成30年度）がんその他の悪性新生物研究助成金 

細胞老化を利用した変異型KRAS肺癌の新規治療薬開発

2018.2

国内共同研究 

クラスター形成関連分子を標的としたEGFR変異肺癌の転移抑制治療の開発

2014.4 - 2016.3

科学研究費補助金 

肺癌の上皮間葉細胞転換原因遺伝子と新規治療標的の探索研究

2011.4 - 2014.3

科学研究費補助金  基盤研究(C)

肺がん治療標的としての上皮間葉系細胞転換（ＥＭＴ）関連分子同定の研究　　　　

2008.4 - 2011.3

科学研究費補助金  基盤研究(C)

佐藤　光夫